Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $2.51 M | -77.08% |
2023 | $10.95 M | 15.72% |
2022 | $9.46 M | -28.5% |
2021 | $13.23 M | 29.75% |
2020 | $10.2 M | -74.29% |
2019 | $39.68 M | 48.24% |
2018 | $26.76 M | 204.1% |
2017 | $8.8 M | 123.23% |
2016 | $3.94 M | -32.13% |
2015 | $5.8 M | -38.86% |
2014 | $9.5 M | 211.03% |
2013 | $3.05 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Novartis NVS | $30.58 M | $84.43 M | ๐จ๐ญ Switzerland |
Gilead Sciences GILD | $32.63 M | $0.25 B | ๐บ๐ธ USA |
Vertex Pharmaceuticals VRTX | $5.48 M | $62.12 M | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | $6.12 M | $33.76 M | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | N/A | $0.94 M | ๐บ๐ธ USA |
Array Technologies ARRY | $6.72 M | $22.76 M | ๐บ๐ธ USA |